Sinceri Senior Living Expands Texas Presence Through New Partnership with CareTrust REIT
HOUSTON, TEXAS / ACCESS Newswire / December 10, 2025 / Sinceri Senior Living is pleased to announce the addition of...
Month: December 2025
Medical Care Technologies Inc. (OTC PINK:MDCE) Subsidiary Real Game Used Achieves Major Milestone in High-End Memorabilia Authentication
With AI-based pattern recognition and game-used wear detection, Real Game Used is pioneering the future of authentication. MESA, ARIZONA /...
Sant’ Andrea University Hospital to Integrate GE HealthCare and Tribun Health’s Enterprise Imaging and Digital Pathology Solutions to Help Improve Patient Care
GE HealthCare and Tribun Health collaboration helps foster enterprise imaging and pathology for oncology CHICAGO, ILLINOIS / ACCESS Newswire /...
Sant’ Andrea University Hospital to Integrate GE HealthCare and Tribun Health’s Enterprise Imaging and Digital Pathology Solutions to Help Improve Patient Care
GE HealthCare and Tribun Health collaboration helps foster enterprise imaging and pathology for oncology CHICAGO, ILLINOIS / ACCESS Newswire /...
Sant’ Andrea University Hospital to Integrate GE HealthCare and Tribun Health’s Enterprise Imaging and Digital Pathology Solutions to Help Improve Patient Care
GE HealthCare and Tribun Health collaboration helps foster enterprise imaging and pathology for oncology CHICAGO, ILLINOIS / ACCESS Newswire /...
FDA Approves Renewal of Canalevia-CA1, Jaguar Health’s Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
Conditional approval extended through December 2026 for the treatment of CID in dogsCID confirmatory effectiveness trial expected to conclude in...
FDA Approves Renewal of Canalevia-CA1, Jaguar Health’s Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
Conditional approval extended through December 2026 for the treatment of CID in dogsCID confirmatory effectiveness trial expected to conclude in...
FDA Approves Renewal of Canalevia-CA1, Jaguar Health’s Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
Conditional approval extended through December 2026 for the treatment of CID in dogsCID confirmatory effectiveness trial expected to conclude in...
Modular Medical Announces Pricing of $4.68 Million Public Offering
SAN DIEGO, CA / ACCESS Newswire / December 10, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"),...
Modular Medical Announces Pricing of $4.68 Million Public Offering
SAN DIEGO, CA / ACCESS Newswire / December 10, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"),...
Aeroflow Health and Molina Healthcare Break Down Barriers to Nutrition and Diabetes Care in South Carolina
The new partnership expands nutrition counseling and DSME services for Molina Commercial and Medicare members statewide to support long-term health...
Technomed Medical Unveils New Double and Triple Hooked Neuromonitoring Probes to Aid in Nerve Preservation
Technomed Medical Unveils New Double and Triple Hooked Neuromonitoring Probes to Aid in Nerve Preservation Surgeons performing complex procedures now...
Technomed Medical Unveils New Double and Triple Hooked Neuromonitoring Probes to Aid in Nerve Preservation
Technomed Medical Unveils New Double and Triple Hooked Neuromonitoring Probes to Aid in Nerve Preservation Surgeons performing complex procedures now...
Technomed Medical Unveils New Double and Triple Hooked Neuromonitoring Probes to Aid in Nerve Preservation
Technomed Medical Unveils New Double and Triple Hooked Neuromonitoring Probes to Aid in Nerve Preservation Surgeons performing complex procedures now...
Technomed Medical Unveils New Double and Triple Hooked Neuromonitoring Probes to Aid in Nerve Preservation
Technomed Medical Unveils New Double and Triple Hooked Neuromonitoring Probes to Aid in Nerve Preservation Surgeons performing complex procedures now...
Roche’s giredestrant reduced risk of invasive disease recurrence or death by 30% in ER-positive early-stage breast cancer
Giredestrant is the only oral SERD to show superior invasive disease-free survival in the adjuvant setting, marking the first significant...
Roche’s giredestrant reduced risk of invasive disease recurrence or death by 30% in ER-positive early-stage breast cancer
Giredestrant is the only oral SERD to show superior invasive disease-free survival in the adjuvant setting, marking the first significant...
24/7 Market News- Kraig Labs Breakthrough Science is Pivoting to Scalable Business
How Decades of Innovation Are Converging for Commercial Spider Silk SuccessDENVER, Dec. 10, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer...
24/7 Market News- Kraig Labs Breakthrough Science is Pivoting to Scalable Business
How Decades of Innovation Are Converging for Commercial Spider Silk SuccessDENVER, Dec. 10, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer...
SCIENTURE and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium
U.S. Losartan market totals $245M annually with 71M prescriptions COMMACK, NY, Dec. 10, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC....